The Centers for Disease Control and Prevention (CDC) recently announced an opportunity for stakeholders to share their individual perspectives on and experiences with pain and pain management, including but not li...

Pain Medicine , AAPM's official journal, recently published a new virtual issue on ketamine. The issue is freely available and includes a collection of preliminary studies, surveys, pragmatic and systematic reviews, and ...

FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information. This will help ensure that heal...

The COVID-19 pandemic has brought unprecedented challenges. The pandemic is also exacerbating other ongoing public health emergencies, including the addiction crisis in the United States. During these challenging times, ...

Today AAPM President Ajay D. Wasan, MD MSc issued the following message to members. Dear Colleagues, I want to keep you apprised of how AAPM is responding to the extraordinary circumstances we are living in this year. Th...

The AAPM Annual Meeting is the perfect venue to disseminate important information to the entire pain medicine field. Poster abstracts will be accepted for the AAPM 37th Annual Meeting, February 3-7, 2021, in Phoenix, AZ....

A new molecular imaging approach utilizing 18F-FDG positron emission tomography (PET) and magnetic resonance imaging (MRI) can precisely identify the location of pain generators in chronic pain sufferers, often precipita...

AppliedVR, announced results from the first randomized controlled trial (RCT), evaluating virtual-reality-based (VR) therapy for self-management of chronic pain at home. The study, which was published in JMIR-FR, found t...

Assess the efficacy of short-term nicotine transdermal patch administration for the treatment of CIPN in cancer stable patients or patients in remission. Read the details .